Hypercalcemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

The prevalence of hypercalcemia in the cancer patient is approximately 3286.23 per 100,000 individuals over the period of 2009 to 2013 in the United States.

Epidemiology and Demographics

Primary hyperparathyroidism is the most common cause of hypercalcemia. For epidemiology and demographics of hyperparathyroidism, click here.

Prevalence

The prevalence of hypercalcemia in the cancer patient is approximately 3286.23 per 100,000 individuals over the period of 2009 to 2013 in the United States.^[1]

References

↑ Gastanaga VM, Schwartzberg LS, Jain RK, Pirolli M, Quach D, Quigley JM; et al. (2016). “Prevalence of hypercalcemia among cancer patients in the United States”. Cancer Med. 5 (8): 2091–100. doi:10.1002/cam4.749. PMC 4899051. PMID 27263488.

Template:WS Template:WH

[pmid27263488-1] Gastanaga VM, Schwartzberg LS, Jain RK, Pirolli M, Quach D, Quigley JM; et al. (2016). “Prevalence of hypercalcemia among cancer patients in the United States”. Cancer Med. 5 (8): 2091–100. doi:10.1002/cam4.749. PMC 4899051. PMID 27263488.

[1]